Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of HIV protease inhibitors with reverse transcriptase inhibitors

Combinations of HIV protease inhibitors with reverse transcriptase inhibitors

US Patent 6166004 · Granted Dec 26, 2000

Estimated economic value: $1,357,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazopyrrolidine derivatives and their use in the treatment of disease2018
Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the tre2017
Pyrrolopyrrolone derivatives and their use as BET inhibitors2017
Pyrirnidinyl aryl urea derivatives being FGF inhibitors2014
Compounds and compositions as protein kinase inhibitors2013
Compounds and compositions as protein kinase inhibitors2013
Pyrimidinyl aryl urea derivatives being FGF inhibitors2012
Heterobicyclic carboxamides as inhibitors for kinases2012
Heterobicyclic carboxamides as inhibitors for kinases2011
Heterobicyclic carboxamides as inhibitors for kinases2011
Phthalazine derivatives with angiogenesis inhibiting activity2011
Phenylacetamides suitable as protein kinase inhibitors2011